Revealed: NZ Medsafe's Safety Assessment of the Pfizer Vaccine for Pregnant Women
Chris James, Group Manager of Medsafe told in Court by an expert, "It is concerning that public health officials did not reveal this atypical feature of Comirnaty."
As part of New Zealand’s provisional approval of the Pfizer vaccine, the country’s regulator Medsafe prepared a Non-Clinical Assessment in January 2021 which concluded that:
the lipid nanoparticles were distributed through the body, mainly into the liver, adrenal glands, spleen and ovaries.
with regard to pregnancy, “alth…
